INMED PHARMACEUTICALS (Germany) Price on February 10, 2024
| MWG0 Stock | 4.17 0.23 5.84% |
If you're considering investing in INMED Stock, it is important to understand the factors that can impact its price. As of today, the current price of INMED PHARMACEUTICALS stands at 4.17, as last reported on the 26th of December, with the highest price reaching 4.17 and the lowest price hitting 4.17 during the day. INMED PHARMACEUTICALS appears to be dangerous, given 3 months investment horizon. INMED PHARMACEUTICALS INC holds Efficiency (Sharpe) Ratio of 0.0604, which attests that the entity had a 0.0604% return per unit of volatility over the last 3 months. By analyzing INMED PHARMACEUTICALS's technical indicators, you can evaluate if the expected return of 0.61% is justified by implied risk. Please utilize INMED PHARMACEUTICALS's risk adjusted performance of 0.0445, and Market Risk Adjusted Performance of 0.5921 to validate if our risk estimates are consistent with your expectations.
INMED Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
INMED |
Sharpe Ratio = 0.0604
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | MWG0 | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 10.04 actual daily | 89 89% of assets are less volatile |
Expected Return
| 0.61 actual daily | 12 88% of assets have higher returns |
Risk-Adjusted Return
| 0.06 actual daily | 4 96% of assets perform better |
Based on monthly moving average INMED PHARMACEUTICALS is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of INMED PHARMACEUTICALS by adding it to a well-diversified portfolio.
INMED PHARMACEUTICALS Valuation on February 10, 2024
It is possible to determine the worth of INMED PHARMACEUTICALS on a given historical date. On February 10, 2024 INMED was worth 5.67 at the beginning of the trading date compared to the closed value of 5.67. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of INMED PHARMACEUTICALS stock. Still, in general, we apply an absolute valuation method to find INMED PHARMACEUTICALS's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of INMED PHARMACEUTICALS where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against INMED PHARMACEUTICALS's related companies.
| Open | High | Low | Close | Volume | |
| 5.54 | 5.54 | 5.43 | 5.54 | 1.00 | |
02/09/2024 | 5.67 | 5.67 | 5.67 | 5.67 | 1.00 |
| 5.86 | 5.86 | 5.86 | 5.86 | 1.00 |
| Backtest INMED PHARMACEUTICALS | | | INMED PHARMACEUTICALS History | Previous | Next |
INMED PHARMACEUTICALS Trading Date Momentum on February 10, 2024
| On February 12 2024 INMED PHARMACEUTICALS INC was traded for 5.86 at the closing time. The maximum traded price for the trading interval was 5.86 and the lowest daily price was 5.86 . There was no trading activity during the period 1.0. Lack of trading volume on 12th of February 2024 played a part in the next trading day price rise. The trading delta at closing time to the next closing price was 3.35% . The trading delta at closing time to the closing price today is 5.29% . |
About INMED PHARMACEUTICALS Stock history
INMED PHARMACEUTICALS investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for INMED is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in INMED PHARMACEUTICALS INC will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing INMED PHARMACEUTICALS stock prices may prove useful in developing a viable investing in INMED PHARMACEUTICALS
INMED PHARMACEUTICALS Stock Technical Analysis
INMED PHARMACEUTICALS technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
INMED PHARMACEUTICALS Period Price Range
Low | December 26, 2024
| High |
0.00 | 0.00 |
INMED PHARMACEUTICALS INC cannot be verified against its exchange. Please verify the symbol is currently traded on Frankfurt Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
INMED PHARMACEUTICALS December 26, 2024 Market Strength
Market strength indicators help investors to evaluate how INMED PHARMACEUTICALS stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading INMED PHARMACEUTICALS shares will generate the highest return on investment. By undertsting and applying INMED PHARMACEUTICALS stock market strength indicators, traders can identify INMED PHARMACEUTICALS INC entry and exit signals to maximize returns
INMED PHARMACEUTICALS Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for INMED PHARMACEUTICALS's price direction in advance. Along with the technical and fundamental analysis of INMED Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of INMED to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0445 | |||
| Jensen Alpha | 0.4015 | |||
| Total Risk Alpha | (0) | |||
| Sortino Ratio | 0.0529 | |||
| Treynor Ratio | 0.5821 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for INMED Stock analysis
When running INMED PHARMACEUTICALS's price analysis, check to measure INMED PHARMACEUTICALS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy INMED PHARMACEUTICALS is operating at the current time. Most of INMED PHARMACEUTICALS's value examination focuses on studying past and present price action to predict the probability of INMED PHARMACEUTICALS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move INMED PHARMACEUTICALS's price. Additionally, you may evaluate how the addition of INMED PHARMACEUTICALS to your portfolios can decrease your overall portfolio volatility.
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |